These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8393158)

  • 21. T-antigen mutant activities in vivo: roles of p53 and pRB binding in tumorigenesis of the choroid plexus.
    Chen J; Tobin GJ; Pipas JM; Van Dyke T
    Oncogene; 1992 Jun; 7(6):1167-75. PubMed ID: 1317542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and DNA polymerase alpha compete for binding to SV40 T antigen.
    Gannon JV; Lane DP
    Nature; 1987 Oct 1-7; 329(6138):456-8. PubMed ID: 3309672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence-specific interaction of a conformational domain of p53 with DNA.
    Srinivasan R; Roth JA; Maxwell SA
    Cancer Res; 1993 Nov; 53(22):5361-4. PubMed ID: 8221671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis.
    Herzig M; Novatchkova M; Christofori G
    Biol Chem; 1999 Feb; 380(2):203-11. PubMed ID: 10195427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type p53 activates transcription in vitro.
    Farmer G; Bargonetti J; Zhu H; Friedman P; Prywes R; Prives C
    Nature; 1992 Jul; 358(6381):83-6. PubMed ID: 1614538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyomavirus large T antigen overcomes p53 dependent growth arrest.
    Doherty J; Freund R
    Oncogene; 1997 Apr; 14(16):1923-31. PubMed ID: 9150359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
    Stürzbecher HW; Brain R; Addison C; Rudge K; Remm M; Grimaldi M; Keenan E; Jenkins JR
    Oncogene; 1992 Aug; 7(8):1513-23. PubMed ID: 1321401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
    Nevels M; Spruss T; Wolf H; Dobner T
    Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
    Härtl B; Zeller T; Blanchette P; Kremmer E; Dobner T
    Oncogene; 2008 Jun; 27(26):3673-84. PubMed ID: 18212738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
    Martin DW; Subler MA; Muñoz RM; Brown DR; Deb SP; Deb S
    Biochem Biophys Res Commun; 1993 Aug; 195(1):428-34. PubMed ID: 8395834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of SV40 T-antigen mutants that alter T-antigen-induced chromosome damage in human fibroblasts.
    Ray FA; Waltman MJ; Lehman JM; Little JB; Nickoloff JA; Kraemer PM
    Cytometry; 1998 Apr; 31(4):242-50. PubMed ID: 9551599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice.
    Bennoun M; Grimber G; Couton D; Seye A; Molina T; Briand P; Joulin V
    Oncogene; 1998 Sep; 17(10):1253-9. PubMed ID: 9771968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
    DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
    Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral growth, origin binding, and p53 binding properties of simian virus 40 large T antigen transformation and replication mutants.
    Rutila JE; Christensen JB; Imperiale MJ
    Oncogene Res; 1989; 4(4):303-10. PubMed ID: 2549490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
    Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
    Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis.
    Chang F; Syrjänen S; Kurvinen K; Syrjänen K
    Am J Gastroenterol; 1993 Feb; 88(2):174-86. PubMed ID: 8424417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Rb and p53 is insufficient for SV40 T-antigen transformation.
    Sachsenmeier KF; Pipas JM
    Virology; 2001 Apr; 283(1):40-8. PubMed ID: 11312660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen.
    O'Neill FJ; Hu Y; Chen T; Carney H
    Oncogene; 1997 Feb; 14(8):955-65. PubMed ID: 9050995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the human c-myc gene by simian virus 40 large T antigen without binding to p53 and RB proteins in the transient expression system.
    Shimazu T; Takada S; Ishida S; Ueno Y; Koike K
    Biochem Biophys Res Commun; 1997 Jun; 235(1):153-7. PubMed ID: 9196053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.